Therigy is pleased to share the release of a new ambulatory assessment within TherigySTM.
TherigySTM is known for specialty patient care plans but often our specialty pharmacies and health system clients are caring for both specialty and non-specialty patients. Our clinicians at Therigy have developed an ambulatory assessment that includes therapy management for hypertension, hyperlipidemia, obesity, cardiovascular disease, and diabetes.
The new ambulatory assessment streamlines therapy management, (a) enhancing the quality-of-care specialty pharmacies offer to ambulatory patients and (b) monitoring real-world outcomes to reduce hospital readmission rates. These are goals that pharmacies, patients, health systems, and payors can all thoroughly support.
The ambulatory assessment also offers specialty pharmacies best practices and guidelines for caring for ambulatory patients. It allows the pharmacist to ensure the patient is adequately educated on the medications they’re taking, identify lifestyle changes that might be beneficial, increase patient adherence to treatment, track outcomes, and manage follow-up treatment. A pharmacist can quickly review a patient chart to determine the diagnosis, review medications, and reconcile therapies.
For instance, a diabetes patient may go into the hospital already taking an antacid, receive a prescription for a new antacid with a different dose, and walk out of the hospital with a prescription for duplicate therapy, not realizing they should only be taking one of the antacids. The ambulatory assessment will enable pharmacists to identify issues like this through a medication reconciliation, determine the overlap, and address it directly with the patient and prescriber, avoiding adverse consequences and additional costs.
This assessment offers a range of other capabilities, such as the following:
- SMART Goals: Pharmacists can set goals collaboratively with the patient in order to achieve better therapy outcomes and provide useful data to the clinician.
- Side Effects: The assessment provides the clinician the ability to evaluate, manage, and triage a patient’s side effects and then monitor them on an ongoing basis.
- Follow Up: The assessment directs pharmacists to set up timely follow-up appointments with the patient.
- Patient Reported Outcomes: Pharmacists can use outcomes to assess the efficacy of treatment, monitor disease progression or control, and gain insight on therapeutic benefit from a clinical and patient-reported aspect.
Beyond these great benefits, TherigySTM’s ambulatory assessment is adaptable to every pharmacy’s specific needs. It reports trends to facilitate a holistic approach to patient care outside of the hospital, improving outcomes and avoiding readmission.
To learn more, contact a Therigy expert today!